Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vorinostat with Salvage Chemotherapy in Elderly R/R AML
NCT01039363Phase 2Unknown
- Sponsor
- Samsung Medical Center
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of vorinostat in acute myeloid leukemia (AML), sponsored by Samsung Medical Center. Status: unknown.
02
Drugs
vorinostat
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT01039363.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01039363.